![Birgitte Volck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Birgitte Volck
Geen lopende functies
Vermogen: 7 238 $ op 31-07-2026
Profiel
Momenteel bekleedt Birgitte Volck de functie van SVP, Head-Clinical Development & Medical Affairs bij Ascendis Pharma A. Dr. Volck is ook lid van de raad van bestuur van Soleno Therapeutics, Inc. en Vaccibody AS. Dr. Volck bekleedde voordien de volgende functies: Head-Research & Development bij GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development bij Swedish Orphan Biovitrum AB, President-Research & Development bij Avrobio, Inc., Director-Executive Development bij Amgen, Inc., Director-Nordic Medical & Project Director bij Genzyme Danmark en Head-Clinical Development & Medical Affairs bij Pharmexa A. Birgitte Volck behaalde een doctoraat aan de Universiteit van Kopenhagen.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-12-2024 | 20.311 ( 0,01% ) | 7 238 $ | 31-07-2026 |
Eerdere bekende functies van Birgitte Volck
| Bedrijven | Functie | Einde |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Directeur/Bestuurslid | 15-05-2026 |
OMass Therapeutics Ltd.
 OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops native mass spectrometry platform | Directeur/Bestuurslid | 28-01-2026 |
| NYKODE THERAPEUTICS | Directeur/Bestuurslid | 30-12-2024 |
| ASCENDIS PHARMA A/S | Hoofd Techniek/Wetenschap/O&O | 01-12-2023 |
| TECTONIC THERAPEUTIC, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2020 |
Opleiding van Birgitte Volck
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
74
Eerstegraads connecties
14
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services Provides clinical trial and contract research services | Commercial Services |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
TFS Trial Form Support International AB
 TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services Operates as clinical contract research organization | Commercial Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Genzyme Danmark | |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company focusing in treatment of Wilson disease | Health Technology |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
OMass Therapeutics Ltd.
OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops native mass spectrometry platform | Commercial Services |
